FYI
"Respected Florida based US research house Redchip, has re-rated ASX listed cancer drug hopeful Pharmaust at 35c a share, almost triple its current share price. The total Net Present Value calculated by Redchip for Pharmaust out to 2030 is $56.5m, considerably higher than Pharmaust's current market cap that hovers between $10m and around $12m. "
Full article:
https://www.businessnews.com.au/article/US-research-house-tips-Pharmaust-shares-to-triple?utm
Respected Florida based US research house Redchip, has re-rated ASX listed cancer drug hopeful Pharm
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.025(12.2%) |
Mkt cap ! $95.01M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 22.5¢ | $916.3K | 3.892M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6654 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 152097 | 3 |
View Market Depth
| Last trade - 15.41pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.0¢ |
Change
0.025 ( 12.2 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.5¢ | 22.5¢ | 1712220 | ||
| Last updated 15.54pm 05/06/2024 ? | |||||
| PAA (ASX) Chart |